Trending...
- Real Estate Experts Highlight Jersey Shore as a Smart Buy in 2025
- West Dentistry Welcomes New Oral Surgeon to Enhance Patient Care
- Cynthia Pinot Among Artists Selected for Renowned London Art Biennale 2025
NEW YORK - Michimich -- STS Capital Partners is pleased to announce the appointment of Ross Toohey as a Managing Director. A founder-turned-M&A strategist with a track record of building, scaling, and successfully exiting businesses, Ross brings over two decades of experience across entrepreneurship, corporate development, and strategic advisory. Having led his own company through a premium private equity exit and advised others on both buy- and sell-side transactions, Ross offers a uniquely holistic perspective that enhances STS's ability to deliver Extraordinary Exits™ for founder-led and mid-market companies.
Ross began his entrepreneurial journey as CEO of 2e Group, a privately-owned omnichannel pharma/biotech commercialization agency that he scaled into one of North America's largest independent firms. He spearheaded strategic acquisitions and market expansions, positioning the business as a dominant industry force and securing an elite roster of Fortune 100 clients.
More on Michimich.com
In 2019, Ross led the successful sale of 2e Group to medical communications leader Fishawack Health (now Avalere Health). Post-acquisition, he was appointed Chief Commercial Officer, overseeing corporate business development and M&A. During his tenure, Ross pioneered the now-ubiquitous concept of fully integrated pharma commercialization, helping drive the company's growth to over $1.1 billion in enterprise value.
Following his success in corporate M&A, Ross founded EONOVA, an exit planning and advisory firm. Through EONOVA, he leverages his expertise in leadership, strategic growth, and both buy- and sell-side M&A to help business owners identify valuation gaps, plan successful exits, and accelerate enterprise value. He is a sought-after strategic growth consultant, particularly for businesses in healthtech, pharma/biotech, and professional services.
Ross is a Certified Exit Planning Advisor (CEPA) and serves as Mid-Americas U.S. Regional Board Chairman-Elect for the Young Presidents' Organization (YPO).
More on Michimich.com
"Ross has sat in the founder's seat, scaled a business into a market leader, and achieved a premium exit. Now, as an STS Managing Director, he draws on that firsthand experience to help our clients do the same – maximizing value and creating extraordinary outcomes," said Sean Friday, CEO of STS Capital Partners.
About STS Capital Partners:
STS Capital Partners is a global sell-side M&A firm like no other. We are expert guides for private, founder, and entrepreneurial business owners on the journey to achieving an Extraordinary Exit™. Our extensive global relationships, world-class team, and proven deal process bring international strategic buyers and investors to the table who deliver maximum financial value. As a result, we help clients fulfill bigger ambitions in life and leave lasting legacies by inspiring charitable donations through our Success to Significance™ program with a goal of raising billions of dollars in new philanthropic and impact capital to support charities like Altruvest, Knowledge Impact Network, and DignityMoves.
Ross began his entrepreneurial journey as CEO of 2e Group, a privately-owned omnichannel pharma/biotech commercialization agency that he scaled into one of North America's largest independent firms. He spearheaded strategic acquisitions and market expansions, positioning the business as a dominant industry force and securing an elite roster of Fortune 100 clients.
More on Michimich.com
- Wolverine Glass Explains 3 Different Types of Shower Door Glass
- Michigan Commercial Debt Collector Says that Summer is Strategy Season!
- Ann Arbor Chiropractor Explains Causes, Symptoms, and Treatment for Carpal Tunnel
- NSG Provides IT and Cybersecurity Tech Support to Ann Arbor Businesses!
- Miami Real Estate Agent Drastically Increases Interest In Homes
In 2019, Ross led the successful sale of 2e Group to medical communications leader Fishawack Health (now Avalere Health). Post-acquisition, he was appointed Chief Commercial Officer, overseeing corporate business development and M&A. During his tenure, Ross pioneered the now-ubiquitous concept of fully integrated pharma commercialization, helping drive the company's growth to over $1.1 billion in enterprise value.
Following his success in corporate M&A, Ross founded EONOVA, an exit planning and advisory firm. Through EONOVA, he leverages his expertise in leadership, strategic growth, and both buy- and sell-side M&A to help business owners identify valuation gaps, plan successful exits, and accelerate enterprise value. He is a sought-after strategic growth consultant, particularly for businesses in healthtech, pharma/biotech, and professional services.
Ross is a Certified Exit Planning Advisor (CEPA) and serves as Mid-Americas U.S. Regional Board Chairman-Elect for the Young Presidents' Organization (YPO).
More on Michimich.com
- Adostics & Genmega Announce the Introduction of A-POD
- Trenton Rotary Club awards Five $2500 Business Grants
- LIB and Nidec Rejoin Forces for Giant TH-0098 Temperature Humidity Test Chamber
- Heritage at South Brunswick Offers Immediate Townhome Appointments and Special Mortgage Incentive Fast-Moving Sales
- NASA Collaborative Agreement for Supply of Thin-Film Solar Tech for Orbital Application to Advance Development of Thin-Film PV Power Beaming: $ASTI
"Ross has sat in the founder's seat, scaled a business into a market leader, and achieved a premium exit. Now, as an STS Managing Director, he draws on that firsthand experience to help our clients do the same – maximizing value and creating extraordinary outcomes," said Sean Friday, CEO of STS Capital Partners.
About STS Capital Partners:
STS Capital Partners is a global sell-side M&A firm like no other. We are expert guides for private, founder, and entrepreneurial business owners on the journey to achieving an Extraordinary Exit™. Our extensive global relationships, world-class team, and proven deal process bring international strategic buyers and investors to the table who deliver maximum financial value. As a result, we help clients fulfill bigger ambitions in life and leave lasting legacies by inspiring charitable donations through our Success to Significance™ program with a goal of raising billions of dollars in new philanthropic and impact capital to support charities like Altruvest, Knowledge Impact Network, and DignityMoves.
Source: STS Capital Partners
Filed Under: Business
0 Comments
Latest on Michimich.com
- Bach and Beyond: Cellists Return to the Beach for 2nd Annual Bethany Beach Cellofest
- NR7 Miner launches zero-cost USDT cloud mining service: daily stable income + referral rewards for double profit
- Deaths Spur Closures, but Troubled Teen Camps Must Be Banned, CCHR Warns
- Hillside Terrace Champions Lifelong Learning in Assisted Living
- Veteran Criminal Defense Attorney Offers Strategic DUI Defense and License Reinstatement
- Ann Arbor Criminal Defense Attorney Urges Residents to Be Informed During Police Encounters
- ArborMotion Highlights the Importance of Timely Brake Replacement for European Vehicles
- EASTSIDE GOLF OPENS FIRST U.S. STOREFRONT IN DETROIT
- Palmer Lake Wine Festival To Build Bridges in Small Mountain Community, Highlight Local Businesses
- SacraPod Suites Unveils AI-Powered 'Work + Rest' Smart Hospitality Model for Retrofitting Underused Motels Across the U.S
- From Real Estate to Reel Power: H.L Woods Carves His Legacy as a Cutting-Edge Visionary Filmmaker
- 'Unity Through Christ Music Festival' coming to Detroit Saturday August 9, 2025
- New Release: 'The Invisible Alternative' Unveiled by Atrisk Corporation, Resilient
- Cynthia Pinot Among Artists Selected for Renowned London Art Biennale 2025
- Real Estate Experts Highlight Jersey Shore as a Smart Buy in 2025
- Top 5 Mistakes Entrepreneurs Make When Applying for SBA Loans
- Michigan Computer Supplies Expands Reach into Livingston County with New Brighton Service Offerings
- $18 Price Target Issued in New Research Report After $34 Million Revenue Forecast from Acquisition; $101.5 Million Net Revenue in 2025; NAS DAQ: IQST
- West Dentistry Welcomes New Oral Surgeon to Enhance Patient Care
- Delta Industrial Provides Custom Flatwork for Factory Floors